Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours.
about
Methylseleninic acid restricts tumor growth in nude mice model of metastatic breast cancer probably via inhibiting angiopoietin-2PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancerRelative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurementAngiopoietin-like 4 stimulates STAT3-mediated iNOS expression and enhances angiogenesis to accelerate wound healing in diabetic miceProlyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancerReversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacyIntratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas.In vivo microcartography and subcellular imaging of tumor angiogenesis: a novel platform for translational angiogenesis research.The vascular response induced by transmyocardial laser revascularization is determined by the size of the channel scar: Results of CO2, holmium and excimer lasers.The associated expression of Maspin and Bax proteins as a potential prognostic factor in intrahepatic cholangiocarcinomaIdentification of a characteristic vascular belt zone in human colorectal cancerImmunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancerAssessment of angiogenesis by CD105 antigen in epithelial salivary gland neoplasms with diverse metastatic behavior.Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytomaIn situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization.The role of microvessel density, lymph node metastasis, and tumor size as prognostic factors of distant metastasis in colorectal cancer.CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.Hepatocellular carcinomas in cirrhotic and noncirrhotic human livers share angiogenic characteristics.Molecular imaging of metastatic potential.Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphomaMetronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiationStudy of microvessel density and the expression of vascular endothelial growth factors in adrenal gland pheochromocytomas.Modification of cyclic NGR tumor neovasculature-homing motif sequence to human plasminogen kringle 5 improves inhibition of tumor growth.Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia.Tumor interstitial fluid pressure-a link between tumor hypoxia, microvascular density, and lymph node metastasisAngiogenesis in the progression of cutaneous squamous cell carcinoma: an immunohistochemical study of endothelial markers.The clinical impact of mean vessel size and solidity in breast carcinoma patients.Primary tumor vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact.Breast Tumor Angiogenesis and Tumor-Associated Macrophages: Histopathologist's PerspectiveBevacizumab in the treatment of patients with advanced breast cancer: where have we landed?TFIIB-related factor 2 over expression is a prognosis marker for early-stage non-small cell lung cancer correlated with tumor angiogenesis.Osteosarcoma microenvironment: whole-slide imaging and optimized antigen detection overcome major limitations in immunohistochemical quantification.Whole slide quantification of stromal lymphatic vessel distribution and peritumoral lymphatic vessel density in early invasive cervical cancer: a method description.High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.Improved survival in osteosarcoma patients with atypical low vascularization.Assessment of bone vascularization and its role in bone remodeling.The effect of bone marrow concentrate and hyperbaric oxygen therapy on bone repair.Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.
P2860
Q21261285-6AA2FBC9-E967-4C79-AEFB-00B0D831F970Q24304449-0C652A31-AEEF-4227-A663-9374D9D41DFEQ24797550-C8FE9BCF-FC9B-404C-B7D7-07654A9FF322Q28084794-CAFF6629-E0EC-4C56-B6D8-3F148C45E472Q28241438-72477F1C-4EB7-46AA-923C-4C2C7865FEBEQ28244168-3BB99260-3ACE-4CFD-B30F-50C0073DA34AQ30366115-3A7DECA3-C72B-47BF-B921-F68C81A1AB36Q30466624-27AC4E6C-114B-476C-B3ED-A1BB45CC313BQ30490037-93653260-C9F9-4D91-B5EB-23C52B0A1A06Q31101269-7D6B5A4C-D89C-4FC7-A0FC-13C7A5D4B083Q33261661-74F433E8-E959-4A69-8329-E359A8EC37C0Q33364892-9AE3E54E-0AA8-477D-8E32-B12CC0A3EFA0Q33428339-9814460F-FE40-4825-B1AE-E9E00D4A192DQ33514953-D8991F6F-5695-456B-AC37-6A85D143E9B3Q33580374-664DE4C5-A46D-4722-8284-9AF1CB08A9B5Q33687901-ECD732F1-7B05-4DD2-A722-64B914473ECCQ33751209-7BFC6762-1460-4EEA-9274-CCC459A81600Q33788042-C7E103AA-F921-4EAA-BC37-12B6423DF0B0Q33843943-BD41BF73-7493-455D-A402-384D834003F1Q33917943-B698EE27-8244-4E9F-B454-F5CD5817D890Q34097528-1C9B8D8E-8E6D-44A2-A42B-3A7F8F2F0CA4Q34155610-EADB2345-761E-4720-B833-CD3B1D26906DQ34158974-610D9A45-649F-4B11-85E8-A4C96C2B61CBQ34206444-BFBAAC91-D16D-40CC-928C-5CB244CF71E0Q34271190-8E717CCE-5C84-4CD0-ACB6-2B72E6A64F44Q34300600-EF44636A-DC06-4BC9-8086-11B87F86AF80Q34347257-6AEC2BC9-37FD-41C6-9430-191E06224904Q34768754-06589138-CA71-4F33-BFA7-B1188FC7DA6DQ35022553-726B8EBF-57B4-4CAA-BDCE-77A98C351110Q35027303-23C011BC-BE86-4C06-AC2C-6EF03264AB20Q35055683-846DCB91-A826-473D-8FE8-CFEB09A475E5Q35076287-A3B06BFE-55F0-406B-9706-BC8E4947DE5BQ35093552-6485BBA9-05E6-47D8-8340-3D7BC9AF55E7Q35110990-530654A8-F19F-40DF-BB0C-05C40367F146Q35184814-A427D381-69C0-446F-A32B-A82FD286E107Q35188596-D25BB7B6-97AE-4149-A84C-B146BCC997D8Q35231406-B4FEB207-6A5A-47D9-80BD-5A9A4B8B8E64Q35316988-903FB0AF-7D6F-471C-8766-BA18CF2D1258Q35541142-CA5269F1-4609-405D-A316-B9A8470E71F4Q35581064-DE198284-A9C3-46FB-BBB7-6E2A13B0B9FD
P2860
Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Second international consensus ...... cation in solid human tumours.
@ast
Second international consensus ...... cation in solid human tumours.
@en
Second international consensus ...... cation in solid human tumours.
@nl
type
label
Second international consensus ...... cation in solid human tumours.
@ast
Second international consensus ...... cation in solid human tumours.
@en
Second international consensus ...... cation in solid human tumours.
@nl
prefLabel
Second international consensus ...... cation in solid human tumours.
@ast
Second international consensus ...... cation in solid human tumours.
@en
Second international consensus ...... cation in solid human tumours.
@nl
P2093
P1476
Second international consensus ...... cation in solid human tumours.
@en
P2093
Colpaert C
Gasparini G
Van Marck E
Vermeulen PB
P304
P356
10.1016/S0959-8049(02)00094-1
P577
2002-08-01T00:00:00Z